Track topics on Twitter Track topics that are important to you
EGEN, Inc., is a privately held biopharmaceutical company located in Huntsville, Alabama and is focused on developing therapeutics for the treatment of human diseases via nucleic acid (DNA and RNAi) delivery. The Company has a significant intellectual property position in delivery systems, their novel compositions with nucleic acids and their therapeutic applications. EGEN's research pipeline includes products involving siRNA, shRNA and plasmid DNA for the treatment of various cancers and other diseases and has a number of collaborations with outside investigators, biotech organizations and universities on various projects in these areas.
HUNTSVILLE, Ala., Sept. 26, 2011 /PRNewswire/ -- EGEN, Inc. is collaborating with the National Cancer Institute's Nanotechnology Characterization Laboratory in Frederick, Md., to accelerate human clin...
RATIONALE: Biological therapies, such as EGEN-001, may stimulate the immune system in different ways and stop tumor cells from growing. PURPOSE: This phase II clinical trial is studying t...
Ovarian cancer may be caused by a build-up of genetic defects, or damaged genes within the cells of the body. Because the genes are damaged, the body is unable to produce a group of protei...
Ovarian cancer may be caused by a build-up of genetic defects, or damaged genes within the body's cells. When genes are damaged, the body may be unable to produce a group of proteins, call...
The task consists in reach as much bubbles as they can, the bubbles appear on the screen of the computer and should be reached in 10 seconds. To accomplish that, three different devices wi...
EGEN, Inc., is a privately held biopharmaceutical company located in Huntsville, Alabama and is focused on developing therapeutics for the treatment of human diseases via nucleic acid (DNA and RNAi) d...
Expression Genetics, Inc. (EGEN), is a privately held biopharmaceutical company specializing in nucleic acid (DNA and RNAi) delivery and therapeutics aimed at specific disease targets. The Company...
An Alabama-based specialty biopharmaceutical company developing safe and efficient polymeric delivery systems to be used to create products for treatment of human diseases. Our delivery vehicles, base...
We have published hundreds of EGEN, Inc. news stories on BioPortfolio along with dozens of EGEN, Inc. Clinical Trials and PubMed Articles about EGEN, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EGEN, Inc. Companies in our database. You can also find out about relevant EGEN, Inc. Drugs and Medications on this site too.
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...